INS and diabetes mellitus: In addition to inflammation, impaired insulin signaling and glucose metabolism, hallmarks of diabetes, may play a role in the development and progression of Parkinson's disease, therefore understanding the molecular framework that links both diseases is expected to facilitate the development of novel therapeutic strategies.